Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Titel:
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Auteur:
Oaknin, Ana Gladieff, Laurence Martínez-García, Jerónimo Villacampa, Guillermo Takekuma, Munetaka De Giorgi, Ugo Lindemann, Kristina Woelber, Linn Colombo, Nicoletta Duska, Linda Leary, Alexandra Godoy-Ortiz, Ana Nishio, Shin Angelergues, Antoine Rubio, Maria Jesús Fariñas-Madrid, Lorena Yamaguchi, Satoshi Lorusso, Domenica Ray-Coquard, Isabelle Manso, Luis Joly, Florence Alarcón, Jesús Follana, Philippe Romero, Ignacio Lebreton, Coriolan Pérez-Fidalgo, J Alejandro Yunokawa, Mayu Dahlstrand, Hanna D'Hondt, Véronique Randall, Leslie M